Skip to content
Screener

Opko Health OPK Retained Earnings

Retained Earnings at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$10.37B+7.1%
Regenxbio logo
RegenxbioRGNX
-$1.19B-19.7%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$1.01B+26.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$4.81B-13.9%
PTH
Pelthos TherapeuticsPTHS
-$75.03M-220%
Exelixis logo
ExelixisEXEL
-$262.53M-19.6%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemJune 30, 2026December 31, 2025
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively7,7627,900
Treasury Stock - 30,174,907, and 30,849,907 shares at June 30, 2026 and December 31, 2025, respectively(2,363)(3,176)
Additional paid-in capital3,561,1143,574,942
Accumulated other comprehensive loss(28,393)(21,017)
Accumulated deficit(2,353,954)(2,290,690)
Total shareholders’ equity1,184,1661,267,959
Total liabilities and equity$1,829,453$1,931,944

Item 1. Financial Statements

FAQ

What is Opko Health's retained earnings?
Opko Health (OPK) reported retained earnings of -$2.35B in Q2 2026.
How has Opko Health's retained earnings changed year-over-year?
Opko Health's retained earnings decreased by 3.2% year-over-year, from -$2.28B to -$2.35B.
What is the long-term trend for Opko Health's retained earnings?
Over 5 years (2020 to 2025), Opko Health's retained earnings has grown at a 9.1% compound annual growth rate (CAGR), from -$1.48B to -$2.29B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Opko Health's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude